MEDICAL MARIJUANA, INC. HOME

Axim Biotechnologies

CBD industry top

Medical Marijuana, Inc. Records Best Revenue Quarter in Company History

Important achievements from across our portfolio of companies helped drive record revenue and continued success…
CBD for migraines

AXIM® Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment

Medical Marijuana, Inc. investment AXIM® Biotechnologies looks to expand impressive intellectual property portfolio with patent…
biggest CBD company

How Medical Marijuana, Inc. Worked to Advance the Cannabis Industry in the Past Year

This 4/20, we look at how our family of companies have helped to support the…
CBD cannabis pharmaceuticals

AXIM Biotechnologies to Begin Clinical Studies on THC and CBD Chewing Gum Treatments

Recent agreement with research organization initiates studies on potential cannabinoid treatments for drug-related psychosis and…
CBD industry

Medical Marijuana, Inc. Family of Companies Surpass Last Year’s Revenue with 5 Months Left in 2018

Medical Marijuana, Inc. rides momentum from first half of the year to pass last year’s…

Medical Marijuana, Inc. Major Investment AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules

SAN DIEGO, Feb. 28, 2018 -- Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the…
medical marijuana research news

MMJ Reporter Trumpets Dutch Scientists’ Landmark Trial Tests of CanChew® Plus from AXIM® Biotechnologies

A marijuana-focused news outlet recently spotlighted MJNA investment company AXIM® Biotechnologies and its upcoming trial…

AXIM Biotechnologies Takes First Steps Towards Clinical Trials for CBD-Based Treatment of Drug-Related Psychosis

Since securing additional funding last fall, AXIM® Biotechnologies has expanded its ongoing new drug research…

Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related Psychosis

SAN DIEGO, Aug. 3, 2017 -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company…

The CBD Hemp Oil Movement – and Medical Marijuana, Inc.’s place in it.

Since 2012, Medical Marijuana, Inc. has been recognized as an industry leader in the CBD…

Medical Marijuana, Inc Major Investment AXIM Biotech Enters Agreement With Israel-Based CRO To Begin Clinical POC Study For Treatment Of Restless Leg Syndrome

SAN DIEGO, July 27, 2017 -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United…

AXIM® Biotechnologies to Explore Cannabinoid-Based Treatment for Restless Leg Syndrome

AXIM® Biotechnologies has taken the steps necessary to begin Phase II clinical trials on a…